Skip to search formSkip to main contentSkip to account menu

Male Castration

Known as: Bilateral orchiectomy, castration male, Male Castrations 
National Institutes of Health

Related topics

Related topics

8 relations
Ablation

Broader (4)

CastrationEndocrine Surgical ProceduresExcisionSexual sterilization

Narrower (3)

OrchiectomyRadical bilateral orchiectomyUnilateral orchiectomy

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Prostate cancer incidence in orchidectomised male‐to‐female transsexual persons treated with oestrogens
Male‐to‐female transsexual persons (MtoF) undergo treatment with antiandrogens and oestrogens followed by bilateral orchiectomy… 
Highly Cited
2003
Highly Cited
2003
Frozen section analysis-guided organ-sparing approach in testicular tumors: technique, feasibility, and long-term results.
Highly Cited
1999
Highly Cited
1999
Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer.
PURPOSE Hot flashes may be a significant clinical problem in men undergoing androgen deprivation therapy with gonadotropin… 
Highly Cited
1998
Highly Cited
1998
Quality of life in advanced prostate cancer: results of a randomized therapeutic trial.
Highly Cited
1998
Highly Cited
1998
Maximal Androgen Blockade: Final Analysis of EORTC Phase III Trial 30853
Objectives: This prospective, randomized phase III study was initiated to compare the efficacy and side effects of bilateral… 
Review
1995
Review
1995
Estrogens in the treatment of prostate cancer.
Highly Cited
1995
Highly Cited
1995
Nitric oxide mediated erectile activity is a testosterone dependent event: a rat erection model.
Classically, androgens were thought to be linked to sexual activity in man through their action on increased libido. Recently… 
Highly Cited
1993
Highly Cited
1993
Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III EORTC trial (30853). EORTC GU Group and EORTC Data Center.
Highly Cited
1991
Highly Cited
1991
Prostate specific antigen in hormonally treated stage D2 prostate cancer: is it always an accurate indicator of disease status?
Highly Cited
1988
Highly Cited
1988
The European Organization for Research and Treatment of Cancer (EORTC).
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)